P. Bakke (Bergen, Norway), F. Kauffmann (Villejuif, France)
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease
M. Dahl, M. Thomsen, T. Ingebrigtsen, J. Marott, P. Lange, J. Vestbo, B. Nordestgaard (Copenhagen, Herlev, Frederiksberg, Odense, Denmark)
|  |
Systemic inflammation and lung function in adulthood and their association with early life factors
N. J. Saad, M. Kaakinen, A. Da Silva Couto Alves, M. R. Jarvelin, P. G. J. Burney (London, United Kingdom; Oulu, Finland)
| |
Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations
S. Tangedal, M. Aanerud, P. Aukrust, G. HusebØ, J. Hardie, L. Persson, P. Bakke, T. Eagan (Bergen, Oslo, Norway)
|  |
Characteristics and consequences of chronic obstructive pulmonary disease in never smokers
P. Lange, M. Thomsen, B. Nordestgaard, J. Vestbo (Copenhagen, Herlev, Odense, Denmark)
| |
GOLD classifications and mortality in COPD: The HUNT study
L. Leivseth, B. M. Brumpton, T. I. L. Nilsen, X. M. Mai, R. Johnsen, A. Langhammer (Trondheim, Levanger, Norway)
| |
Comparison of 2011 and 2007 GOLD guidelines for predicting mortality and hospitalization
A. Johannessen, R. M. Nilsen, M. StorebØ, A. Gulsvik, T. Eagan, P. Bakke (Bergen, Norway)
| |
The bronchitic phenotype is related to morbidity and mortality - report from the OLIN COPD study
A. Lindberg, L. Hedman, S. Sawalha, E. Rönmark, B. Lundbäck (Umeå, Luleå, Gothenburg, Sweden)
| |
Lung function (LF) decline and hospitalization in subjects with the asthma-COPD overlap syndrome
R. de Marco, A. Marcon, J. Antó, I. Cerveri, T. Gislason, J. Heinrich, C. Janson, D. Jarvis, N. Kuenzli, B. Leynaert, C. Svanes, M. Wjst, P. Burney (Verona, Pavia, Italy; Barcelona, Spain; Reykjavik, Iceland; Neuherberg, Munich, Munich, Germany; Uppsala, Sweden; London, United Kingdom; Basel, Switzerland; Paris, France; Bergen, Norway)
| |